Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Aggarwal

Showing results (151-160 of 262) with videos related to

Pageof 27
Sort By:
Clinical and Experimental Rheumatology|July 15, 2024
Brepocitinib, a potent and selective TYK2/JAK1 inhibitor: scientific and clinical rationale for dermatomyositisJulie J Paik, Jiri Vencovský, Christina Charles-Schoeman, et al.
Clinical and Experimental Rheumatology|December 2, 2025
Health-related quality of life improvements and response thresholds of myositis outcome measures and response criteriaMaha Almackenzie, Anushka Aggarwal, Shiri Keret, et al.
Clinical Rheumatology|June 26, 2025
Long-term clinical prognosis of anti-aminoacyl-tRNA synthetase antibodies and interstitial lung diseaseKoichi Yamaguchi, Daniel I Sullivan, Singh Khushboo, et al.
Rheumatology (Oxford, England)|March 14, 2021
Reliability, validity and responsiveness of physical activity monitors in patients with inflammatory myopathyBonny Rockette-Wagner, Didem Saygin, Siamak Moghadam-Kia, et al.
ACR Open Rheumatology|July 8, 2024
Relationship between Jo-1 B Cell Epitope Profile and Clinical Features of Anti-Synthetase SyndromeKoichi Yamaguchi, Qi Tang, Joseph J LaConti, et al.
Rheumatology (Oxford, England)|August 26, 2024
Comparative B cell epitope profiling in Japanese and North American cohorts of MDA5+ dermatomyositis patients reveals a direct association between immune repertoire and pulmonary mortalityKoichi Yamaguchi, Paul Poland, Lei Zhu, et al.
Rheumatology (Oxford, England)|February 1, 2022
A systematic review and meta-analysis of mycobacterial infections in patients with idiopathic inflammatory myopathiesSaloni Haldule, Moumita Chatterjee, Rudra Prosad Goswami, et al.
Seminars in Arthritis and Rheumatism|September 13, 2020
Relationship between change in physical activity and in clinical status in patients with idiopathic inflammatory myopathy: A prospective cohort studyOcéane Landon-Cardinal, Damien Bachasson, Perrine Guillaume-Jugnot, et al.
Rheumatology International|August 30, 2024
Heterogeneity in nomenclature and abbreviation usage for anti-synthetase syndrome: a scoping reviewAnushka Aggarwal, Tanya Chandra, Parth Ladha, et al.
BMC Musculoskeletal Disorders|September 19, 2015
Biologic predictors of clinical improvement in rituximab-treated refractory myositisAnn M Reed, Cynthia S Crowson, Molly Hein, et al.
Pageof 27

Showing results (151-160 of 262) with videos related to

Sort By:
Pageof 27
Clinical and Experimental Rheumatology|July 15, 2024
Brepocitinib, a potent and selective TYK2/JAK1 inhibitor: scientific and clinical rationale for dermatomyositisJulie J Paik, Jiri Vencovský, Christina Charles-Schoeman, et al.
Clinical and Experimental Rheumatology|December 2, 2025
Health-related quality of life improvements and response thresholds of myositis outcome measures and response criteriaMaha Almackenzie, Anushka Aggarwal, Shiri Keret, et al.
Clinical Rheumatology|June 26, 2025
Long-term clinical prognosis of anti-aminoacyl-tRNA synthetase antibodies and interstitial lung diseaseKoichi Yamaguchi, Daniel I Sullivan, Singh Khushboo, et al.
Rheumatology (Oxford, England)|March 14, 2021
Reliability, validity and responsiveness of physical activity monitors in patients with inflammatory myopathyBonny Rockette-Wagner, Didem Saygin, Siamak Moghadam-Kia, et al.
ACR Open Rheumatology|July 8, 2024
Relationship between Jo-1 B Cell Epitope Profile and Clinical Features of Anti-Synthetase SyndromeKoichi Yamaguchi, Qi Tang, Joseph J LaConti, et al.
Rheumatology (Oxford, England)|August 26, 2024
Comparative B cell epitope profiling in Japanese and North American cohorts of MDA5+ dermatomyositis patients reveals a direct association between immune repertoire and pulmonary mortalityKoichi Yamaguchi, Paul Poland, Lei Zhu, et al.
Rheumatology (Oxford, England)|February 1, 2022
A systematic review and meta-analysis of mycobacterial infections in patients with idiopathic inflammatory myopathiesSaloni Haldule, Moumita Chatterjee, Rudra Prosad Goswami, et al.
Seminars in Arthritis and Rheumatism|September 13, 2020
Relationship between change in physical activity and in clinical status in patients with idiopathic inflammatory myopathy: A prospective cohort studyOcéane Landon-Cardinal, Damien Bachasson, Perrine Guillaume-Jugnot, et al.
Rheumatology International|August 30, 2024
Heterogeneity in nomenclature and abbreviation usage for anti-synthetase syndrome: a scoping reviewAnushka Aggarwal, Tanya Chandra, Parth Ladha, et al.
BMC Musculoskeletal Disorders|September 19, 2015
Biologic predictors of clinical improvement in rituximab-treated refractory myositisAnn M Reed, Cynthia S Crowson, Molly Hein, et al.
Pageof 27